Pharma BD Deal Intelligence

Teva Pharmaceutical Industries Ltd. / Sicor Inc.

2003 · Acquisition/Merger · $3.4B · Complete

Announcement Sentiment

75

Strongly positive

Outcome Score

68

Largely worked — most objectives met.

Teva acquired Sicor for $3.4B for entry into biosimilars market.

Key facts

Announced Oct 31, 2003
Closed Jan 22, 2004
Deal value $3.4B
Deal type Acquisition/Merger
Indications Injectable generics / biosimilars
Key assets Generic portfolio

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals